Mike B.’s Post

This April 16th, as we observe National Healthcare Decisions Day, let's celebrate not only our right to make informed choices about our healthcare but also the evolving landscape of Decentralized Clinical Trials. Decentralized Clinical Trials (DCTs) are revolutionizing the way we conduct medical research by leveraging digital technologies to bring trials directly to patients. As we commemorate this day, let's recognize the role DCTs play in empowering patients: 💻 Increased accessibility: DCTs eliminate geographic barriers, allowing patients to participate from the comfort of their homes. 🔒 Enhanced privacy: Patients have greater control over their data and can participate in trials with increased confidentiality. 📊 Improved diversity: DCTs enable broader participation, leading to more representative and inclusive research outcomes. This National Healthcare Decisions Day, let's embrace the opportunities presented by Decentralized Clinical Trials and continue to advocate for patient-centered research practices. #NHDD #DecentralizedClinicalTrials #PatientEmpowerment #HealthcareDecisions For getting more information about our DCT activities visit 👉 https://lnkd.in/giFeHCYj

“The global community should use lessons from the COVID-19 pandemic as a mandate for improved pandemic preparedness” - #100DaysMission Science and Technology Expert Group and IPPS Deputy Head Charlotte Baker in a new opinion piece for The Lancet. They set out 5 recommendations for a new medical countermeasures network to deliver equity and innovation: 1. Equitable access needs to be embedded in new products 2. Enhanced international coordination for R&D to make best use of limited funding 3. Develop and maintain a global clinical trials network to ensure diagnostics, therapeutics and vaccines are evaluated in regions where they are likely to be used 4. An ambitious preparatory regulatory vision, centred around the strengthening and harmonisation of national requirements 5. Sustainable regional manufacturing strategy to improve diagnostic, therapeutic and vaccine availability and equitable access in low- and middle-income countries, as well as supporting local product confidence 📖🦠🌐 https://lnkd.in/gBW-ZhpC

In its 15th year, the SCOPE Summit 2024 stands as a pivotal gathering in the realm of clinical trials and research, fostering collaborative efforts, innovative solutions, and strategic decision-making. Set to unfold from February 11-14, 2024, the event promises four days of immersive discussions and networking spanning 28 conferences. To know more: https://buff.ly/3DxBQG6 #research #Clinical #Biomarkers #Patient #ClinicalOperations #BiopharmaStrategy #ClinicalDataManagement #PatientRecruitment #Trialdesign #BiospecimenOperations

Lessons Learned from COVID-19: The Future of Clinical Trials What has the clinical research community learned from the COVID-19 pandemic? Explore the key lessons and long-term changes that are set to revolutionize clinical trials. From telemedicine to patient-centric approaches, see how the field is evolving to become more resilient and inclusive. Dive into our latest blog to uncover the future of clinical research. #MedicalResearch #FutureOfHealthcare #COVID19Impact

Great initiative! The synergy between patient participation in research and the tremendous scientific & medical progress we experience today underscores the critical role of patient engagement in shaping the future of healthcare.

Recruiting diverse participants for clinical trials helps ensure the reliability of data. Yet there is no agreed-upon standard for the evidence required to develop digital health technologies (DHTs). Join PLAC's Bridging Health Inequities Webinar with Exponent’s Marta Villarraga, Ph.D., RAC, and Nathalie Horowicz-Mehler, PhD, together with Blake E. Wilson, Esq., of Hogan Lovells as they present, “Bridging Health Inequities with Digital Health Technologies.” This talk will cover four questions for life sciences firms to consider when evaluating the use of DHTs in clinical trials. Register: https://hubs.ly/Q02vrfKG0 Learn more about our Biomedical Engineering & Sciences expertise: https://hubs.ly/Q02vrhW20 Learn more about our Health Sciences expertise: https://hubs.ly/Q02vrctw0 #Exponent #Event #BiomedicalEngineering #HealthSciences #FDA #ClinicalTrials

Check out our upcoming Clinical Leader Live on Friday, September 22nd. ⬇️ https://lnkd.in/dDRa_VXZ 🌟 It's been 3 years since the buzz around Decentralized Clinical Trials (DCTs) started, but is the excitement dying down? 🤔 The pros and cons have been debated, the reality likely falls between traditional site-based trials and the futuristic "site-less" trials where patients use innovative gadgets to transmit data seamlessly. 💡Regulatory authorities have also shared their thoughts, hinting at forthcoming and potentially lasting changes. Catch up with our panelists to get a glimpse into their DCT journey - from hybrids to virtual setups, remote trials, and even home-based approaches. 🏡🔬 Oscar Segurado, MD, PhD & Phil Ambery Curious about the FDA's perspective on DCTs? 📑 We're discussing the topic with Dr. Daniel Fox, MPH, PhD, a site owner and advocate with valuable insights. 🩺💼 The event will be moderated by our own Dan Schell 🚀 #ClinicalTrials #DCTs #FutureOfMedicine #DecentralizedClinicalTrials

Trying to increase patient engagement? Have a look at the findings from my colleagues in the Baringa Pharma and Lifesciences team who ran a live ~200 person workshop to get insights on the key areas to get right in scaling patient engagement within R&D. #pharmaceuticals #biotech #patientengagement #patientvoice #impact

The clinical trial landscape is evolving rapidly, and patient-centric approaches are taking center stage. But are hybrid and decentralized trials truly aligned with patient preferences? Discover the patient perspective on these innovative trial formats at the Data-Driven, Hybrid, and Full Decentralized Clinical Trials conference this April in Philadelphia. Join esteemed industry speakers and gain insights to enhance patient access and satisfaction in your trials. 🚀 Register now for a complimentary pass* to join us in person: https://lnkd.in/e-4S4nDD Don't forget to invite your colleagues too – complimentary passes are limited so secure yours today! Curious about who you'll be networking with? Download the current attendee list here: https://lnkd.in/eP9nAQF4 #ClinicalTrials #PatientCentricity #Innovation #HealthcareConference #DataDrivenTrials #DCT #HybridTrials #DecentralizedTrials #ClinicalInnovation